Below you can find an overview of old and recent Wemos publications. For an overview of more recent publications on human resources for health, finance for health and medicines, please visit our knowledge platform Wemosresources.org.
For more previous annual reports and strategy documents, please visit this page.
2019 Theory of Change
2020 Remco van de Pas and Corinne Hinlopen: Policy brief ‘Global Skills Partnerships on Migration’
2018 Remco van de Pas, Linda Mans, Mariëlle Bemelmans, Anja Krumeich: Framing the Health Workforce Agenda Beyond Economic Growth
2017 Linda Mans, Remco van de Pas, Sascha Marschang: Civil society contributions to a sustainable health workforce in the European Union (in: Public Health Panorama 2017; 3(3):357-536)
2016 Remco van de Pas, Linda Mans, e.a.: The Code of Practice and its enduring relevance in Europe and Eastern and Southern Africa
2015 Amy Davies and Linda Mans: Thuisbezorgd – inwonende buitenlandse zorgverleners als oplossing? (Dutch)
2020 Discussion paper (Aid & Trade): ‘In the interest of health for all? The Dutch ‘Aid & Trade’ agenda as pursued in the African healthcare context’ – Summary brief of this and our other Aid & Trade discussion paper in English and in Dutch
2020 Position paper: COVID-19, SSR&D e sistemas de saúde (Português)
2019 Discussion paper (Aid & Trade): ‘Best public value for public money? The case of match-funded multi-hospital infrastructure development in Tanzania’ – Summary brief of this and our other Aid & Trade discussion paper in English and in Dutch
2019 SOMO & Wemos: ‘Overpriced – Drugs developed with Dutch public funding’
2017 Ella Weggen and Corinne Hinlopen: ‘Independent clinical research: a road towards affordable & valuable medicines’
2017 Pearl Heinemans, Irene Schipper, Patrick Durisch: ‘Transnational pharmaceutical companies’ clinical drug trials in Egypt: ethical questions in a challenging context’ in: Dirty Profits 5.
2016 Annelies den Boer and Amy Davies: ‘Clinical trials in Africa: an exploitative relationship’ in: Dirty Profits 4.
2015 Joint briefing paper: ”Adaptive licensing’ or ‘adaptive pathways’: deregulation under the guise of earlier access’
2014 Position paper: ‘Added Therapeutic Value: European citizens should get their money’s worth’